MONDAY
Recursion Pharmaceuticals, Inc. - Class A
SCoRE: 67
LAST PRICE - AT THE CLOSE
RXRX is DOWN -4% since the begininning of the year
RXRX is UP 17% ABOVE 20 day SMA
RXRX is UP 5% ABOVE 200 day SMA
PROFITABLE: NO
EPS: $-0.39
EARNINGS MOMENTUM: YES
0.05% INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
THE STOCK IS 77.9% AWAY FROM ALL-TIME HIGHS OF $42.81 | |
RXRX IS DOWN -4% SINCE THE BEGINNING OF THE YEAR | |
RXRX IS UP 76% OVER THE PAST 12 MONTHS | |
RXRX IS UP 13% OVER THE PAST 1 MONTH | |
25% OF ALL RXRX INVESTORS ARE BETTING AGAINST RXRX | |
NUM INVESTORS SHORT RXRX HAS GONE UP N/A% VERSUS LAST MONTH |
RXRX moved up 0 in the previous minute | |
RXRX is up 1.58 over the last hour | |
RXRX is up 10.9% over the last 5 days | |
RXRX is 12.8 above its 8 day SMA |
$9.06 | DAY |
$10.40 |
$8.22 | PREVIOUS DAY |
$9.34 |
$8.22 | WEEK |
$9.34 |
$7.13 | MONTH |
$9.40 |
$4.92 | YEAR |
$16.75 |